Examining the Lindsay Clancy Case: Fragmented Healthcare's Risks
The Lindsay Clancy case highlights severe issues within the U.S. healthcare system, revealing the dangers of fragmented care and lack of communication among providers.
Lifestyle trends and health tips
The Lindsay Clancy case highlights severe issues within the U.S. healthcare system, revealing the dangers of fragmented care and lack of communication among providers.
The FDA's removal of clozapine's monitoring requirements is pivotal, but fear still hinders clinicians from prescribing it to young patients with schizophrenia.
The trial's deadlock raises significant concerns for mental health professionals, especially in the context of postpartum care.
A new round of pharmaceutical price cuts has been announced, but crucial details and implications remain unclear.
Recent research reveals that Paxlovid, a popular Covid-19 treatment, offers no benefit for long Covid patients compared to placebo.
The House is poised to vote on a funding bill that would block Trump's initiative to control federal research grants, targeting bipartisan support.
The NIH's recent proposal to limit the number of grants per researcher has sparked varied responses, highlighting ongoing concerns in the biomedical research arena.
MAHA's efforts to reshape American nutrition encounter hurdles stemming from a declining dietitian workforce.
Updated guidelines from leading headache organizations emphasize new migraine treatments while addressing gaps in patient awareness and access.
Novartis' latest drug, pacibekitug, successfully reduces inflammation in a Phase 2 study, suggesting potential for cardiovascular treatment.
The Lindsay Clancy case highlights systemic flaws in maternal mental health care, raising concerns about its impact on psychiatrist willingness to treat patients.
Members of a federal autism advisory committee controversially endorse vaccines as a cause of autism, despite overwhelming scientific refutation.
AstraZeneca's heart disease trial disappoints, showing no added benefit, while a court affirms FDA's handling of drug shortages for prominent diabetes treatments.
Cytokinetics is set to submit aficamten for FDA approval, potentially the first drug approved for non-obstructive hypertrophic cardiomyopathy.
The federal autism advisory committee discusses vaccines as potential autism triggers, sparking controversy amidst calls for more research and transparency.
A year after resigning from the CDC, former staff members highlight ongoing issues and advocate for a reformed public health system free from political bias.
Health Secretary Robert F. Kennedy Jr. faces backlash over vaccine misinformation as PA confirms measles-related deaths; tensions escalate with state officials.
Recent studies highlight how coronary artery calcium scans can inform statin treatment decisions, especially in borderline risk cases.
The FDA has approved Rasonque, a novel treatment for advanced pancreatic cancer, showing significant improvements in patient outcomes.
Pharmaceutical giants are poised to unveil data on new cardiovascular drugs targeting lipoprotein(a), marking a potential breakthrough in treatment.